Author: Nichols Martin|| Date Published: July 8, 2020
Advanced Technology International has been awarded a one-year, $450.4M contract modification by the U.S. Army to produce antibodies to the virus that causes COVID-19.
The branch obligated the full contract amount for ATI’s large-scale antibody manufacturing efforts, the Department of Defense said Tuesday.
Work will take place in Summerville, S.C., and Tarrytown, N.Y., through June 30 next year.
ATI operates as a nonprofit subsidiary of ANSER and serves government customers through research-and-development collaboratins.
CesiumAstro, a global provider of space and defense communications systems and satellites, has acquired artificial intelligence company Vidrovr to strengthen its…
BigBear.ai, provider of artificial intelligence decision intelligence, has closed fiscal 2025 with what CEO Kevin McAleenan, a three-time Wash100 winner,…
L3Harris Technologies has appointed Kenneth “Ken” Sharp as senior vice president and chief financial officer, succeeding current CFO Ken Bedingfield, effective…